Market Research Logo

Nebulizers - Medical Devices Pipeline Assessment, 2018

Nebulizers - Medical Devices Pipeline Assessment, 2018

Summary

GlobalData's Medical Devices sector report, “Nebulizers - Medical Devices Pipeline Assessment, 2018 provides an overview of Nebulizers currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Nebulizers pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Nebulizers under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Nebulizers and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry
Reasons to buy

The report enables you to -
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Nebulizers under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date


1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 6
2 Introduction 7
2.1 Nebulizers Overview 7
3 Products under Development 8
3.1 Nebulizers - Pipeline Products by Stage of Development 8
3.2 Nebulizers - Pipeline Products by Segment 9
3.3 Nebulizers - Pipeline Products by Territory 10
3.4 Nebulizers - Pipeline Products by Regulatory Path 11
3.5 Nebulizers - Pipeline Products by Estimated Approval Date 12
3.6 Nebulizers - Ongoing Clinical Trials 13
4 Nebulizers - Pipeline Products under Development by Companies 14
4.1 Nebulizers Companies - Pipeline Products by Stage of Development 14
4.2 Nebulizers - Pipeline Products by Stage of Development 15
5 Nebulizers Companies and Product Overview 16
5.1 Ablynx NV Company Overview 16
5.1.1 Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview 16
5.2 Aeon Research & Technology Company Overview 19
5.2.1 Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview 19
5.3 AerovectRx Corporation Company Overview 20
5.3.1 AerovectRx Corporation Pipeline Products & Ongoing Clinical Trials Overview 20
5.4 AFT Pharmaceuticals Ltd Company Overview 21
5.4.1 AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview 21
5.5 Aura Medical Company Overview 22
5.5.1 Aura Medical Pipeline Products & Ongoing Clinical Trials Overview 22
5.6 Baby's Breath Ltd. Company Overview 23
5.6.1 Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview 23
5.7 Creare Inc Company Overview 24
5.7.1 Creare Inc Pipeline Products & Ongoing Clinical Trials Overview 24
5.8 DesignWise Medical Inc (Inactive) Company Overview 25
5.8.1 DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 25
5.9 Marquette University Company Overview 26
5.9.1 Marquette University Pipeline Products & Ongoing Clinical Trials Overview 26
5.10 Parion Sciences Inc Company Overview 27
5.10.1 Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview 27
5.11 SolAeroMed Inc Company Overview 30
5.11.1 SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview 30
5.12 Stirling Pharma Inc Company Overview 31
5.12.1 Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview 31
5.13 University of California San Diego Company Overview 32
5.13.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 32
5.14 University of Texas Medical Branch at Galveston Company Overview 33
5.14.1 University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview 33
5.15 Verona Pharma Plc Company Overview 34
5.15.1 Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview 34
6 Nebulizers- Recent Developments 37
6.1 Jan 31, 2018: Owens & Minor Previews 2017 Preliminary Financial Results 37
6.2 Jan 31, 2018: Boehringer Ingelheim Announces Paul Fonteyne to Retire at the end of 2018. Wolfgang Baiker Appointed U.S. President & CEO Effective March 1, 2018. 37
6.3 Jan 02, 2018: Teleflex Completes Previously Announced CEO Transition 38
6.4 Dec 15, 2017: Change in the Board of Managing Directors at Boehringer Ingelheim 39
6.5 Dec 08, 2017: Henry Ford Cardiologist Named to American College of Cardiology Executive Leadership 39
6.6 Nov 29, 2017: Vectura Group appoints Juliet Thompson to its Board of Directors 40
6.7 Nov 06, 2017: Cardinal Health Reports First-quarter Results for Fiscal Year 2018 41
6.8 Nov 06, 2017: Cardinal Health Outlines Leadership Succession Plan 42
6.9 Nov 02, 2017: Teleflex Reports Third Quarter 2017 Results 45
6.10 Nov 01, 2017: Owens & Minor Reports 3rd Quarter 2017 Financial Results 47
6.11 Oct 25, 2017: United Therapeutics Reports Third Quarter 2017 Financial Results 49
6.12 Oct 23, 2017: Healthier Communities 20/20: A Clear Vision for Our Future; Owens & Minor will Explore this Theme at its 12th Annual Healthcare Supplier Diversity Symposium 51
6.13 Sep 27, 2017: Verona Pharma Reports Positive Top-Line Data from U.S. Pharmacokinetic Trial Demonstrating Nebulized RPL554 Delivers Optimal Clinical Dose to Patients 52
6.14 Sep 08, 2017: Dr. Davia Viellechner is the New Managing Director of PARI 53
6.15 Sep 06, 2017: Vectura Group: 2017 Interim Results 53
6.16 Sep 05, 2017: Insmed Announces Positive Top-Line Results from Phase 3 CONVERT Study of ALIS (Amikacin Liposome Inhalation Suspension) in Adult Patients with Treatment-Refractory Nontuberculous Mycobacterial Lung Disease Caused by Mycobacterium Avium Complex 55
6.17 Sep 01, 2017: Adherium Receives U.S. 510(K) Clearance for Next Generation Smartinhaler for AstraZeneca's Symbicort Aerosol Inhaler 56
6.18 Aug 23, 2017: Henry Ford Hospital CEO Announces Retirement 57
6.19 Aug 16, 2017: Global development agreement with Dynavax for lung cancer programme using Vectura’s smart nebuliser technology (VR347) 58
6.20 Aug 11, 2017: New Retail Director joins Drive DeVilbiss 59
6.21 Aug 03, 2017: Teleflex Reports Second Quarter 2017 Results 59
6.22 Aug 02, 2017: Cardinal Health Reports Q4 and Fiscal 2017 Results, Provides 2018 Guidance 61
6.23 Aug 02, 2017: Boehringer Ingelheim Achieves Good Growth in the First Half of 2017 62
6.24 Aug 01, 2017: Owens & Minor Reports 2nd Quarter 2017 Financial Results 63
6.25 Jul 27, 2017: United Therapeutics Reports Second Quarter 2017 Financial Results 65
6.26 Jul 26, 2017: Verona Pharma Doses First Patients in Phase 2b Clinical Trial of RPL554 for COPD Maintenance Treatment 67
6.27 Jun 26, 2017: Henry Ford Welcomes Three New Senior Executives 67
6.28 Jun 15, 2017: Trudell Medical International: Providing patient-focused solutions and reducing health system costs: our journey in the global fight against COPD 68
6.29 Jun 06, 2017: New anaesthesia systems at Africa Health 2017 70
6.30 May 31, 2017: Ventaleon Initiates Challenge Trial with Inhaled Flu Treatment Candidate 70
6.31 May 24, 2017: Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference 71
6.32 May 16, 2017: Boehringer Ingelheim Inaugurates World-Class Biopharmaceutical Manufacturing Facility in China 72
6.33 May 15, 2017: Henry Ford Health System Welcomes New Lansing Based Government Affairs Manager 73
6.34 May 15, 2017: Henry Ford Wyandotte Hospital Welcomes Two Top Leaders 73
6.35 May 04, 2017: Teleflex Reports First Quarter 2017 Results 74
6.36 May 02, 2017: Owens & Minor Reports 1st Quarter 2017 Financial Results 76
6.37 May 01, 2017: Cardinal Health Reports Third-quarter Results for Fiscal Year 2017 77
6.38 Apr 26, 2017: United Therapeutics Reports First Quarter 2017 Financial Results 78
6.39 Apr 21, 2017: Lisa Newman Appointed to Komen Scientific Advisory Board 79
6.40 Apr 21, 2017: Henry Ford Cancer Institute Appoints Vice President, Executive Director 80
6.41 Apr 18, 2017: Cardinal Health updates fiscal 2017 guidance; Provides early outlook for future fiscal years 80
6.42 Apr 05, 2017: Successful financial year 2016 for Boehringer Ingelheim 81
6.43 Apr 04, 2017: Verona Pharma Doses First Patient In Phase 2a Clinical Trial Evaluating RPL554 For Cystic Fibrosis 82
6.44 Apr 03, 2017: Generous Foundation Grant to Help Start New Global Technology Development Program at Henry Ford Health System 83
6.45 Mar 28, 2017: Henry Ford Veteran Doctor Kimberly A. Brown to Help Lead Transplant Institute 84
6.46 Mar 24, 2017: Henry Ford Hospital Dermatologist Named Dermatology Chair 85
6.47 Mar 21, 2017: Vectura Group: Preliminary Results for the nine-month period ended 31 December 2016 86
6.48 Mar 21, 2017: Vectura Group Announces Preliminary Results for the nine-month period ended 31 December 2016 87
6.49 Mar 16, 2017: Owens & Minor Outlined its New Strategic Plan and Reaffirmed its Financial Outlook for 2017 and 2018 at Annual Investor Meeting 88
6.50 Mar 14, 2017: SolAeroMed Shareholder Newsletter 89
6.51 Mar 13, 2017: Owens & Minor Welcomes New EVP of Global Manufacturer Services 90
6.52 Mar 08, 2017: Connecting Career Potential and Company Leadership Earned Cardinal Health Distinction from National Association for Female Executives 90
6.53 Mar 06, 2017: Vectura Group: Board Change 91
6.54 Feb 23, 2017: Ablynx Announces 2016 Full Year Results 91
6.55 Feb 23, 2017: Teleflex Announces Benson Smith to Retire as Chief Executive Officer at End of 2017; Liam Kelly to Succeed Smith as Chief Executive Officer 92
6.56 Feb 23, 2017: Teleflex Reports Fourth Quarter and Full Year 2016 Results; Provides 2017 Guidance 93
6.57 Feb 22, 2017: United Therapeutics Reports 2016 Fourth Quarter And Annual Financial Results 94
6.58 Feb 16, 2017: Owens & Minor Will Locate Its New Client Engagement Center in Downtown Richmond, Virginia 95
6.59 Feb 16, 2017: Vectura achieves £9 million royalty cap from GSK Ellipta® products 96
6.60 Feb 14, 2017: Owens & Minor Reports 4th Quarter & Full-Year 2016 Financial Results 97
6.61 Feb 10, 2017: Owens & Minor Announces That Healthcare Executive Barbara B. Hill Has Been Elected to Its Board of Directors 99
6.62 Feb 10, 2017: Craig R. Smith, Chairman of the Owens & Minor Board of Directors, Announces His Retirement 99
6.63 Feb 07, 2017: Henry Ford Health System Names New Chair of Neurology Department 100
6.64 Feb 07, 2017: Cardinal Health Reports Second-quarter Results for Fiscal Year 2017 100
7 Appendix 103
7.1 Methodology 103
7.2 About GlobalData 106
7.3 Contact Us 106
7.4 Disclaimer 106
1.1 List of Tables
Table 1: Nebulizers - Pipeline Products by Stage of Development
Table 2: Nebulizers - Pipeline Products by Segment
Table 3: Nebulizers - Pipeline Products by Territory
Table 4: Nebulizers - Pipeline Products by Regulatory Path
Table 5: Nebulizers - Pipeline Products by Estimated Approval Date
Table 6: Nebulizers - Ongoing Clinical Trials
Table 7: Nebulizers Companies - Pipeline Products by Stage of Development
Table 8: Nebulizers - Pipeline Products by Stage of Development
Table 9: Ablynx NV Pipeline Products & Ongoing Clinical Trials Overview
Table 10: Customised Infant Inhalation Device - Product Status
Table 11: Customised Infant Inhalation Device - Product Description
Table 12: Ablynx NV - Ongoing Clinical Trials Overview
Table 13: Customised Infant Inhalation Device - A Randomized, Double-blind, Placebo-controlled, Multicenter Dose Ranging Study of ALX-0171 in Infants and Young Children Hospitalized for Respiratory Syncytial Virus Lower Respiratory Tract Infection
Table 14: Aeon Research & Technology Pipeline Products & Ongoing Clinical Trials Overview
Table 15: LYNX Nebulizer - Product Status
Table 16: LYNX Nebulizer - Product Description
Table 17: AerovectRx Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 18: Aerocurrent - Product Status
Table 19: Aerocurrent - Product Description
Table 20: AFT Pharmaceuticals Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 21: NasoSURF - Product Status
Table 22: NasoSURF - Product Description
Table 23: Aura Medical Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Nebican - Product Status
Table 25: Nebican - Product Description
Table 26: Baby's Breath Ltd. Pipeline Products & Ongoing Clinical Trials Overview
Table 27: WiseAir - Product Status
Table 28: WiseAir - Product Description
Table 29: Creare Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 30: DDC-Based Nebulizer - Product Status
Table 31: DDC-Based Nebulizer - Product Description
Table 32: DesignWise Medical Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 33: Self-Contained Nebulizer System - Product Status
Table 34: Self-Contained Nebulizer System - Product Description
Table 35: Marquette University Pipeline Products & Ongoing Clinical Trials Overview
Table 36: Human Powered Nebulizer - Product Status
Table 37: Human Powered Nebulizer - Product Description
Table 38: Parion Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 39: tPAD Device - Product Status
Table 40: tPAD Device - Product Description
Table 41: Parion Sciences Inc - Ongoing Clinical Trials Overview
Table 42: tPAD Device - Evaluation of Regional Lung Deposition of Inhaled Saline using the Trans-nasal Pulmonary Aerosol Delivery Device in Healthy, Non-smoking Adult Subjects
Table 43: SolAeroMed Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 44: S1226 Neublizer System - Product Status
Table 45: S1226 Neublizer System - Product Description
Table 46: Stirling Pharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: High Density Aerosol Drug Delivery Device - Product Status
Table 48: High Density Aerosol Drug Delivery Device - Product Description
Table 49: University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Nebulizer - Product Status
Table 51: Nebulizer - Product Description
Table 52: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Pulse Drug Nebulization System - Product Status
Table 54: Pulse Drug Nebulization System - Product Description
Table 55: Verona Pharma Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: RPL554 Nebulizer - Product Status
Table 57: RPL554 Nebulizer - Product Description
Table 58: Verona Pharma Plc - Ongoing Clinical Trials Overview
Table 59: RPL554 Nebulizer - A Phase IIa, Randomized, Double Blind, Placebo Controlled, Three Way Crossover Study to Assess the Pharmacokinetics of RPL554 Administered to Adult Patients with Cystic Fibrosis
Table 60: RPL554 Nebulizer - Study to Assess the Effect of RPL554 Compared to Placebo in Patients with Moderate to Severe COPD
Table 61: Glossary
1.2 List of Figures
Figure 1: Nebulizers - Pipeline Products by Stage of Development 8
Figure 2: Nebulizers - Pipeline Products by Segment 9
Figure 3: Nebulizers - Pipeline Products by Territory 10
Figure 4: Nebulizers - Pipeline Products by Regulatory Path 11
Figure 5: Nebulizers - Pipeline Products by Estimated Approval Date 12
Figure 6: Nebulizers - Ongoing Clinical Trials 13

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report